Compare Stocks → See this before next week's Fed meeting (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:BCSFNYSE:CONASDAQ:HYACNASDAQ:PACQ Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBCSFBain Capital Specialty Finance$16.11-1.3%$15.67$11.06▼$16.80N/A1.14257,084 shs97,268 shsCOGlobal Cord Blood$1.35$1.49$2.03▼$5.50$164.09M0.16216,519 shsN/AHYACHaymaker Acquisition Corp. III$10.47$9.77$8.92▼$10.52$309.39MN/A31,313 shs79,979 shsPACQPure Acquisition$10.10$10.10$8.51▼$11.77$155.17M0.06188,691 shs229,497 shsThe Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBCSFBain Capital Specialty Finance+0.59%+4.25%+3.03%+5.19%+41.50%COGlobal Cord Blood0.00%+8.00%-10.00%+11.57%-54.81%HYACHaymaker Acquisition Corp. III0.00%0.00%+0.67%+1.51%+16.08%PACQPure Acquisition0.00%0.00%0.00%0.00%0.00%“The Biggest Bubble of All Time” – Here’s What to Do. (Ad)Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried.Just click here.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBCSFBain Capital Specialty Finance0.6468 of 5 stars1.05.01.70.01.00.01.3COGlobal Cord BloodN/AN/AN/AN/AN/AN/AN/AN/AHYACHaymaker Acquisition Corp. IIIN/AN/AN/AN/AN/AN/AN/AN/APACQPure AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBCSFBain Capital Specialty Finance2.00Hold$14.75-8.44% DownsideCOGlobal Cord BloodN/AN/AN/AN/AHYACHaymaker Acquisition Corp. IIIN/AN/AN/AN/APACQPure AcquisitionN/AN/AN/AN/ACurrent Analyst RatingsLatest BCSF, HYAC, PACQ, and CO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails1/29/2024BCSFBain Capital Specialty FinanceWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$13.75 ➝ $14.50(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBCSFBain Capital Specialty Finance$297.79MN/A$1.35 per share11.93N/AN/ACOGlobal Cord Blood$1.24B0.13$0.32 per share4.19$6.34 per share0.21HYACHaymaker Acquisition Corp. IIIN/AN/AN/AN/AN/AN/APACQPure AcquisitionN/AN/A$0.36 per share27.83$0.48 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBCSFBain Capital Specialty Finance$123.38M$1.908.488.26N/A41.43%12.54%5.49%5/6/2024 (Confirmed)COGlobal Cord Blood$79.04M$0.642.11∞N/AN/AN/AN/AN/AHYACHaymaker Acquisition Corp. IIIN/AN/A0.00∞N/AN/AN/AN/AN/APACQPure Acquisition$3.79MN/A56.11∞N/AN/A-5.71%-0.12%N/ALatest BCSF, HYAC, PACQ, and CO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2024N/ABCSFBain Capital Specialty Finance$0.53N/A-$0.53N/AN/AN/A 2/27/2024Q4 2023BCSFBain Capital Specialty Finance$0.54$0.54N/A$0.60N/A$74.95 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBCSFBain Capital Specialty Finance$1.6810.43%+3.82%88.42%2 YearsCOGlobal Cord Blood$0.085.93%N/A12.50%N/AHYACHaymaker Acquisition Corp. IIIN/AN/AN/AN/AN/APACQPure AcquisitionN/AN/AN/AN/AN/ALatest BCSF, HYAC, PACQ, and CO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/27/2024BCSFBain Capital Specialty FinanceQuarterly$0.4511.58%3/27/20243/28/20244/30/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBCSFBain Capital Specialty Finance1.112.182.18COGlobal Cord BloodN/AN/AN/AHYACHaymaker Acquisition Corp. IIIN/AN/AN/APACQPure AcquisitionN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipBCSFBain Capital Specialty FinanceN/ACOGlobal Cord BloodN/AHYACHaymaker Acquisition Corp. III71.07%PACQPure Acquisition72.05%Insider OwnershipCompanyInsider OwnershipBCSFBain Capital Specialty Finance0.55%COGlobal Cord Blood0.50%HYACHaymaker Acquisition Corp. IIIN/APACQPure Acquisition22.50%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBCSFBain Capital Specialty Finance1,000N/AN/AOptionableCOGlobal Cord Blood1,202121.55 millionN/ANo DataHYACHaymaker Acquisition Corp. III429.55 millionN/ANot OptionablePACQPure AcquisitionN/A15.36 millionN/ANot OptionableBCSF, HYAC, PACQ, and CO HeadlinesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesUndervalued UnitedHealth Group Won’t Be For LongApril 16, 2024 10:53 AMView Undervalued UnitedHealth Group Won’t Be For LongHere are the Pros and Cons of Using Options Call Debit SpreadsApril 11, 2024 11:03 PMView Here are the Pros and Cons of Using Options Call Debit SpreadsCarMax: Is There a Silver Lining to the Earnings Car Wreck? April 22, 2024 8:55 AMView CarMax: Is There a Silver Lining to the Earnings Car Wreck? What is the Nasdaq? Complete Overview with HistoryApril 16, 2024 8:00 AMView What is the Nasdaq? Complete Overview with HistoryHere are the Pros and Cons of Using Options Put Credit Spreads April 18, 2024 8:20 AMView Here are the Pros and Cons of Using Options Put Credit Spreads All Headlines Company DescriptionsBain Capital Specialty FinanceNYSE:BCSFBain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.Global Cord BloodNYSE:COGlobal Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Haymaker Acquisition Corp. IIINASDAQ:HYACHaymaker Acquisition Corp. III does not have any significant operations. It intends to acquire and operate a business in the consumer and consumer-related products. The company was incorporated in 2020 and is based in New York, New York.Pure AcquisitionNASDAQ:PACQPure Acquisition Corp. engages in the provision of merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination. It focuses on energy industry with an emphasis on opportunities in the upstream oil and gas industry in North America. The company was founded on November 13, 2017 and is headquartered in Fort Worth, TX. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
